BACKGROUND: Pelvic recurrence of @entity5 is a life-threatening event for @entity1 . The main therapeutic challenge is to locally control such relapses. We present our experience of the surgical treatment of @entity5 relapses. @entity1 AND METHODS: From July 1980 to January 1994, 49 @entity1 underwent a surgical procedure for @entity5 relapse. Forty four @entity5 relapses were localized in the pelvis and 5 were associated with distant metastases. Surgery was performed alone in 31 cases and in association with radiotherapy in 18 cases. Median follow-up was 34 months. RESULTS: The treatment was curative in 49% of cases. There was a significant correlation between the initial stage, the site of @entity5 relapse and surgical curability. Overall actuarial survival was 44% and 24% at 2 and 5 years, respectively. In the curative treatment group, actuarial survival was 71% and 47% at 2 and 5 years, respectively. There was a major surgical complication in 14 cases: 11 reoperations were performed. Thirteen @entity1 are alive of whom 12 with no evidence of disease (median follow-up; 36 months). A local control was achieved in 53% of cases. Age and site of relapse significantly influenced survival. CONCLUSIONS: The results of this study are comparable with other surgical series despite our less favorable @entity1 selection. For @entity1 experiencing pelvic side-wall infiltration, surgical treatment is a worthwhile palliation in selected cases because it is often the only available therapeutic option.

[Pelvic recurrence of XXXX of the uterine cervix. A study of a series of 49 cases].

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cervical cancer', 'pelvic cervical cancer'] @entity1 :: ('9606', 'Species') :: ['patients', 'patient', 'PATIENTS']
@entity5 :: (MESH:D009369,Disease) :: ['cancers']
